More
    HomeTagsCFAO SAS

    CFAO SAS

    Nigerian E-Mobility Startup MAX Extends Series B3 to $29M with Backing from Nithio

    The company reported in January 2026 that it had reached profitability in Nigeria, its largest and most complex market.

    “We Think in Generations”: Boehringer Places Fresh Bets on Women’s Health and Emerging Markets

    With 80% of its €50m impact fund deployed, Boehringer Ingelheim is backing startups tackling last-mile medicine delivery, e-pharmacy, and affordable outpatient care.
    spot_img

    No posts to display

    Latest articles

    Nigerian E-Mobility Startup MAX Extends Series B3 to $29M with Backing from Nithio

    The company reported in January 2026 that it had reached profitability in Nigeria, its largest and most complex market.

    “We Think in Generations”: Boehringer Places Fresh Bets on Women’s Health and Emerging Markets

    With 80% of its €50m impact fund deployed, Boehringer Ingelheim is backing startups tackling last-mile medicine delivery, e-pharmacy, and affordable outpatient care.

    Inside OPay’s New York IPO: Who Wins Big in Africa’s Landmark Fintech Exit?

    From a Chinese gaming billionaire's iron grip to a clever board seat workaround, here is what’s really hidden in OPay’s 247-page SEC filing.

    Is African Healthtech Facing a Terminal Diagnosis?

    Funding has plunged to an eight-year low, shutdowns are mounting, and commercial VCs are nowhere to be seen. Inside the sector’s grant-dependency crisis.